NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Mankind Pharma Medical Dialogues Team25 Jun 2021 5:22 PM ISTNew Delhi: Giving the benefits of patent expiry of popular antidiabetic drug, Dapagliflozin to consumers, the National Pharmaceutical Pricing...
Mankind Pharma, BDR Pharma partner for COVID drug Baricitinib in India Ruchika Sharma25 Jun 2021 2:00 PM ISTNew Delhi: Mankind Pharma has recently announced that the company has partnered with BDR Pharmaceuticals International Pvt. Ltd for distributing the...
Mankind Pharma launches Dapagliflozin brand Justoza for diabetes, heart failure, CKD Ruchika Sharma23 Jun 2021 1:30 PM ISTNew Delhi: Mankind Pharma has launched Justoza, a Dapagliflozin brand marketed by Mankind to treat Diabetes, Heart Failure and Chronic...
Mankind Pharma gets CDSCO panel nod for trial of anti diabetic molecule, MKP10241 Medical Dialogues Team20 Jun 2021 10:00 AM ISTNew Delhi: Approving the Investigational New Drug (IND) application for Novel Anti Diabetic Molecule, MKP10241, the Subject Expert Committee (SEC) of...
Mankind Pharma MaskMyIndia campaign asks people not to step out without mask Ruchika Sharma2 Jun 2021 10:00 AM ISTNew Delhi: India is still grappling with the second wave of Covid-19 and continues to report over 1.5 lakh cases in a day. Mankind Pharma has...
Mankind Pharma grants Rs 40 crore to COVID patients struggling for oxygen cylinders, concentrators Ruchika Sharma18 May 2021 12:22 PM ISTThe company has decided to arrange around 3,000-3,500 each oxygen cylinders and concentrators which will be distributed pan India in different...
Mankind Pharma, Accenture collaborate to accelerate drugmaker's digital transformation Ruchika Sharma4 May 2021 12:00 PM ISTNew Delhi: Mankind Pharma, the fourth largest pharmaceutical manufacturing company headquartered in India, has collaborated with Accenture to...
Mankind pharma in talks with Russia to market Sputnik V Covid-19 vaccine: Report Medical Dialogues Team22 April 2021 2:35 PM ISTNew Delhi: Delhi-based Mankind Pharma recently announced that it is in discussions with Russia to market the Sputnik V COVID-19 vaccine, reports Money...
Mankind Pharma submits new drug application with CDSCO for anti diabetic molecule MKP10241 Ruchika Sharma15 April 2021 1:38 PM ISTNew Delhi: Mankind Pharma, the 4th largest pharmaceutical company in India (As per IQVIA) has submitted its first Investigational New Drug (IND)...
NPPA panel fixes price of Vildagliptin, Metformin Hydrochloride FDC marketed by Mankind Pharma Medical Dialogues Team24 March 2021 6:17 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) Committee has recommended the retail price of Fixed-Dose Combination (FDC) of...
NPPA brings Remoglifozin, Metformin combination under price control, pulls up Mankind, Intas Pharma for unapproved launch Farhat Nasim15 Jan 2021 7:06 PM ISTNew Delhi: In its recent most attempt to bring drugs under price control, NPPA has now set the maximum price for the FDC of Remoglifozin Etabonate and...
NPPA to issue show-cause notice to Intas, Mankind Pharma for selling diabetes drug sans approval MD Bureau2 Jan 2021 4:56 PM ISTNew Delhi: Coming down on Mankind Pharma and Intas Pharmaceuticals, the National Pharmaceutical Pricing Authority (NPPA) has decided to issue...
